Compare Oscar Health Inc (OSCR) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Under Armour Inc Class A — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Under Armour Inc Class A trades at $4.78 (market cap $2.07B). The key difference: Oscar Health Inc is far larger — about 4.9× Under Armour Inc Class A's market cap, and Oscar Health Inc is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Under Armour Inc Class A for 18 Days on average.
| OSCR | UA | |
|---|---|---|
Market Cap | $10.22B | $2.07B |
Volume | 4,123,394 | 2,680,141 |
Sector | Health | Consumer Cyclical |
52-Week High | $33.81 | $7.88 |
52-Week Low | $10.85 | $3.96 |
Typical Hold Time | 15 Days | 18 Days |
Enterprise Value | $6.57B | $3.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Under Armour (UA) trades at $4.78, up 1.7% with a bullish technical signal despite negative profitability metrics. The company reported mixed quarterly results with two beats and one miss, while revenue declined to $4.9B in 2026 with a net loss of $492M. Analyst consensus shows 40% buy ratings but sentiment remains cautious due to ongoing revenue challenges and negative cash flow trends.
The outlook remains challenging with declining revenue and persistent losses, though the stock's low P/S ratio of 0.41 offers valuation support. Key risks include weak North American demand and competitive pressures, while potential catalysts require successful execution of turnaround strategies to restore profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
